Global Playbook: Divi’s Labs Leads India’s Pharma Shift Beyond the US
India’s pharmaceutical sector is undergoing a notable transformation, moving beyond its heavy reliance on the United States market..According to data from ACE Equity, Divi’s Laboratories leads this transformation, with an impressive 74% of its revenue coming from ROW markets. This diversification...
Easy & quick